Literature DB >> 26400185

Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism.

Victoria Sid1, Nan Wu1, Lindsei K Sarna2, Yaw L Siow3, James D House4, Karmin O5.   

Abstract

AMPK is an endogenous energy sensor that regulates lipid and carbohydrate metabolism. Nonalcoholic fatty liver disease (NAFLD) is regarded as a hepatic manifestation of metabolic syndrome with impaired lipid and glucose metabolism and increased oxidative stress. Our recent study showed that folic acid supplementation attenuated hepatic oxidative stress and lipid accumulation in high-fat diet-fed mice. The aim of the present study was to investigate the effect of folic acid on hepatic AMPK during high-fat diet feeding and the mechanisms involved. Male C57BL/6J mice were fed a control diet (10% kcal fat), a high-fat diet (60% kcal fat), or a high-fat diet supplemented with folic acid (26 mg/kg diet) for 5 wk. Mice fed a high-fat diet exhibited hyperglycemia, hepatic cholesterol accumulation, and reduced hepatic AMPK phosphorylation. Folic acid supplementation restored AMPK phosphorylation (activation) and reduced blood glucose and hepatic cholesterol levels. Activation of AMPK by folic acid was mediated through an elevation of its allosteric activator AMP and activation of its upstream kinase, namely, liver kinase B1 (LKB1) in the liver. Consistent with in vivo findings, 5-methyltetrahydrofolate (bioactive form of folate) restored phosphorylation (activation) of both AMPK and LKB1 in palmitic acid-treated HepG2 cells. Activation of AMPK by folic acid might be responsible for AMPK-dependent phosphorylation of HMG-CoA reductase, leading to reduced hepatic cholesterol synthesis during high-fat diet feeding. These results suggest that folic acid supplementation may improve cholesterol and glucose metabolism by restoration of AMPK activation in the liver.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  AMP; AMP-activated protein kinase; folic acid; liver kinase B1; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2015        PMID: 26400185      PMCID: PMC4666937          DOI: 10.1152/ajpregu.00260.2015

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  66 in total

1.  Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.

Authors:  Nan Wu; Lindsei K Sarna; Sun-Young Hwang; Qingjun Zhu; Pengqi Wang; Yaw L Siow; Karmin O
Journal:  Biochim Biophys Acta       Date:  2013-05-04

2.  The regulation of AMP-activated protein kinase by phosphorylation.

Authors:  S C Stein; A Woods; N A Jones; M D Davison; D Carling
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  Nutritional deficiencies in liver disease.

Authors:  C M Leevy; H Baker
Journal:  Med Clin North Am       Date:  1970-03       Impact factor: 5.456

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 5.  Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Yurie Soejima; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

6.  Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.

Authors:  Piia Simonen; Anna Kotronen; Maarit Hallikainen; Ksenia Sevastianova; Janne Makkonen; Antti Hakkarainen; Nina Lundbom; Tatu A Miettinen; Helena Gylling; Hannele Yki-Järvinen
Journal:  J Hepatol       Date:  2010-08-22       Impact factor: 25.083

7.  SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.

Authors:  Xiuyun Hou; Shanqin Xu; Karlene A Maitland-Toolan; Kaori Sato; Bingbing Jiang; Yasuo Ido; Fan Lan; Kenneth Walsh; Michel Wierzbicki; Tony J Verbeuren; Richard A Cohen; Mengwei Zang
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

Review 8.  Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK.

Authors:  Anthony J A Wright; Jack R Dainty; Paul M Finglas
Journal:  Br J Nutr       Date:  2007-07-09       Impact factor: 3.718

9.  Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.

Authors:  Hae-Ki Min; Ashwani Kapoor; Michael Fuchs; Faridoddin Mirshahi; Huiping Zhou; James Maher; John Kellum; Russell Warnick; Melissa J Contos; Arun J Sanyal
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

10.  AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation.

Authors:  Graeme J Gowans; Simon A Hawley; Fiona A Ross; D Grahame Hardie
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

View more
  10 in total

1.  Short Term High Fat Diet Induces Obesity-Enhancing Changes in Mouse Gut Microbiota That are Partially Reversed by Cessation of the High Fat Diet.

Authors:  Yue Shang; Ehsan Khafipour; Hooman Derakhshani; Lindsei K Sarna; Connie W Woo; Yaw L Siow; Karmin O
Journal:  Lipids       Date:  2017-04-20       Impact factor: 1.880

2.  Vitamins and non-alcoholic fatty liver disease: A Molecular Insight.

Authors:  Sana Raza; Archana Tewari; Sangam Rajak; Rohit A Sinha
Journal:  Liver Res       Date:  2021-04-04

3.  High-fat diet consumption reduces hepatic folate transporter expression via nuclear respiratory factor-1.

Authors:  Victoria Sid; Yaw L Siow; Yue Shang; Connie W Woo; Karmin O
Journal:  J Mol Med (Berl)       Date:  2018-09-04       Impact factor: 4.599

4.  Prepregnancy Habitual Intakes of Total, Supplemental, and Food Folate and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study.

Authors:  Mengying Li; Shanshan Li; Jorge E Chavarro; Audrey J Gaskins; Sylvia H Ley; Stefanie N Hinkle; Xiaobin Wang; Ming Ding; Griffith Bell; Anne A Bjerregaard; Sjurdur F Olsen; James L Mills; Frank B Hu; Cuilin Zhang
Journal:  Diabetes Care       Date:  2019-04-22       Impact factor: 19.112

5.  Folate Metabolism Regulates Oligodendrocyte Survival and Differentiation by Modulating AMPKα Activity.

Authors:  Qinjie Weng; Jiajia Wang; Jiaying Wang; Biqin Tan; Jing Wang; Haibo Wang; Tao Zheng; Q Richard Lu; Bo Yang; Qiaojun He
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

6.  Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα.

Authors:  Feng-Zhi Xin; Ze-Hua Zhao; Rui-Nan Zhang; Qin Pan; Zi-Zhen Gong; Chao Sun; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

7.  Folic Acid Affects Iron Status in Female Rats with Deficiency of These Micronutrients.

Authors:  Joanna Suliburska; Katarzyna Skrypnik; Agata Chmurzyńska
Journal:  Biol Trace Elem Res       Date:  2019-09-11       Impact factor: 3.738

Review 8.  The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer's Disease.

Authors:  Ancuta-Veronica Lupaescu; Monica Iavorschi; Mihai Covasa
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

9.  Association of Folic Acid Supplementation in Early Pregnancy with Risk of Gestational Diabetes Mellitus: A Longitudinal Study.

Authors:  Hongyan Chen; Yaqiong Hu; Yannan Li; Wenzheng Zhou; Niya Zhou; Huan Yang; Qing Chen; Yawen Li; Qiao Huang; Zhen Chen
Journal:  Nutrients       Date:  2022-09-29       Impact factor: 6.706

10.  Preventive effects of folic acid on Zika virus-associated poor pregnancy outcomes in immunocompromised mice.

Authors:  Yogy Simanjuntak; Hui-Ying Ko; Yi-Ling Lee; Guann-Yi Yu; Yi-Ling Lin
Journal:  PLoS Pathog       Date:  2020-05-11       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.